Export 20 results:
Author Title Type [ Year(Desc)]
Filters: Author is VanVeldhuisen, Paul  [Clear All Filters]
2012
J. L. Wiggs, Yaspan, B. L., Hauser, M. A., Kang, J. H., R Allingham, R., Olson, L. M., Abdrabou, W., Fan, B. J., Wang, D. Y., Brodeur, W., Budenz, D. L., Caprioli, J., Crenshaw, A., Crooks, K., Delbono, E., Doheny, K. F., Friedman, D. S., Gaasterland, D., Gaasterland, T., Laurie, C., Lee, R. K., Lichter, P. R., Loomis, S., Liu, Y., Medeiros, F. A., McCarty, C., Mirel, D., Moroi, S. E., Musch, D. C., Realini, A., Rozsa, F. W., Schuman, J. S., Scott, K., Singh, K., Stein, J. D., Trager, E. H., VanVeldhuisen, P., Vollrath, D., Wollstein, G., Yoneyama, S., Zhang, K., Weinreb, R. N., Ernst, J., Kellis, M., Masuda, T., Zack, D., Richards, J. E., Pericak-Vance, M., Pasquale, L. R., and Haines, J. L., Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma., PLoS Genet, vol. 8, no. 4, p. e1002654, 2012.
A. N. C. Campbell, Nunes, E. V., Miele, G. M., Matthews, A., Polsky, D., Ghitza, U. E., Turrigiano, E., Bailey, G. L., VanVeldhuisen, P., Chapdelaine, R., Froias, A., Stitzer, M. L., Carroll, K. M., Winhusen, T., Clingerman, S., Perez, L., McClure, E., Goldman, B., and A Crowell, R., Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network., Contemp Clin Trials, vol. 33, no. 2, pp. 386-95, 2012.
T. Winhusen, Brady, K. T., Stitzer, M., Woody, G., Lindblad, R., Kropp, F., Brigham, G., Liu, D., Sparenborg, S., Sharma, G., VanVeldhuisen, P., Adinoff, B., and Somoza, E., Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world., Contemp Clin Trials, vol. 33, no. 5, pp. 993-1002, 2012.
2016
L. - T. Wu, McNeely, J., Subramaniam, G. A., Sharma, G., VanVeldhuisen, P., and Schwartz, R. P., Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool., Contemp Clin Trials, vol. 50, pp. 90-7, 2016.
L. R. Metsch, Feaster, D. J., Gooden, L., Matheson, T., Stitzer, M., Das, M., Jain, M. K., Rodriguez, A. E., Armstrong, W. S., Lucas, G. M., Nijhawan, A. E., Drainoni, M. - L., Herrera, P., Vergara-Rodriguez, P., Jacobson, J. M., Mugavero, M. J., Sullivan, M., Daar, E. S., McMahon, D. K., Ferris, D. C., Lindblad, R., VanVeldhuisen, P., Oden, N., Castellón, P. C., Tross, S., Haynes, L. F., Douaihy, A., Sorensen, J. L., Metzger, D. S., Mandler, R. N., Colfax, G. N., and del Rio, C., Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial., JAMA, vol. 316, no. 2, pp. 156-70, 2016.
L. - T. Wu, Brady, K. T., Spratt, S. E., Dunham, A. A., Heidenfelder, B., Batch, B. C., Lindblad, R., VanVeldhuisen, P., Rusincovitch, S. A., Killeen, T. K., and Ghitza, U. E., Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study., Contemp Clin Trials, vol. 46, pp. 30-38, 2016.